NCT01001936View on ClinicalTrials.gov

Study Evaluating SKI-606 in Subject With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Tumors

Interventions

DRUG

SKI-606

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT01001936 - Study Evaluating SKI-606 in Subject With Solid Tumors | Biotech Hunter | Biotech Hunter